More About Me

I am a physician-scientist with combined training in cancer biology and clinical medicine. My research focuses on the development of immune effector cell therapies for cancer. I also maintain an active clinic for patients with benign or malignant hematologic conditions. I joined BMC in 2021 as founding Director of the Cellular Therapy Program, whose core mission is to enable equitable patient access to innovative and powerful cancer cell therapies such as CART.

Overall, I have 15+ years of hematology/oncology experience. I completed my MD and oncology training in Italy and then did a fellowship in cancer biology at Harvard. I was on the Harvard faculty for 2 years prior to joining BUSM sponsored by a NIH grant. For 4 years, I worked in industry as Medical Director of investigational CAR T cell therapies for various hematologic malignancies, including ide-cel approved for multiple myeloma in 2021. I am currently a full-time faculty at BUSM and an Attending Physician at BMC.

  • Residency

    Oncology, University of Ferrara, Italy
  • Fellowship

    Research Fellowship, Program in Cellular and Molecular Medicine, Harvard Medical School, Boston, MA
  • Board Certifications

    Oncology (Italy)
  • Special Interests

    Hematologic malignancies
  • Languages

    Italian
  • Location

    830 Harrison Ave
    3rd Floor
    Boston, MA 02118
  • Pronouns

    He/Him